Estrogen Receptor β
Authors:
- Mamoun YounesMYMamoun Younes
- Naoko HonmaNHNaoko Honma
Open Access
- 1 January 2011
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 135 (1) , 63-66
Abstract
Context —A new class of estrogen receptors was discovered in 1996 and named estrogen receptor β (ER-B); the traditional estrogen receptor, which until a little more than 10 years ago was thought of as the only estrogen receptor in existence, is now called estrogen receptor α. Estrogen receptor β has at least 5 isoforms, which may have different functions and have different tissue distribution. The significance of ER-B expression in tumors was first demonstrated in breast cancer, with several studies demonstrating that women with ER-B–positive breast cancers treated with adjuvant tamoxifen have better survival, independent of estrogen receptor α expression. Pathologists need to be more aware of this increasingly important protein, as it will soon find its way into routine clinical practice. Objective —To provide pathologists with a concise review of ER-B, with special emphasis on current and potential clinical relevance. Data Sources —A search of the English literature in PubMed (National Library of Medicine, Bethesda, Maryland) for articles with titles including “estrogen receptor beta,” with emphasis on “immunohistochemistry.” Abstracts were reviewed, and selected articles were used as the basis for writing this review, mostly based on their relevance to pathology. Conclusions —Estrogen receptor β and its isoforms have wider tissue distribution, including the gastrointestinal tract, lung, and brain, than the traditional estrogen receptor, now called estrogen receptor α. Estrogen receptor β expression in breast cancer is associated with favorable outcome in women treated with adjuvant tamoxifen, even in tumors negative for estrogen receptor α. The clinical significance of ER-B expression in tumors other than breast is currently under investigation.Keywords
This publication has 32 references indexed in Scilit:
- Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer lineCancer Letters, 2009
- Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen TherapyJournal of Clinical Oncology, 2008
- Estrogen receptor beta in the brain: From form to functionBrain Research Reviews, 2008
- Estrogen receptor β expression in vascular neoplasia: an analysis of 53 benign and malignant casesLaboratory Investigation, 2004
- Estrogen receptor beta (ER?) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasmJournal of Cancer Research and Clinical Oncology, 2004
- Estrogen receptor βFEBS Letters, 2002
- Differential Expression of Estrogen Receptor β (ERβ) and Its C-Terminal Truncated Splice Variant ERβcx as Prognostic Predictors in Human Prostatic CancerBiochemical and Biophysical Research Communications, 2001
- Cloning and Characterization of Human Estrogen Receptor β IsoformsBiochemical and Biophysical Research Communications, 1998
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996